DENISE GARNER - 21 Sep 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
SVP - Chief Innovation Officer
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
21 Sep 2021
Net transactions value
+$121,274
Form type
4
Filing time
23 Sep 2021, 19:21:16 UTC
Previous filing
23 Aug 2021
Next filing
22 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $129,870 +793 +7.7% $163.77 11,047 21 Sep 2021 Direct F1
transaction CLX Common Stock Tax liability $8,596 -53 -0.48% $162.19 10,996 22 Sep 2021 Direct F2, F3
holding CLX Common Stock 2,178 21 Sep 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Stock Option (Right to Buy) Award $0 +5,836 $0.000000 5,836 21 Sep 2021 Common Stock 5,836 $163.77 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units will vest in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025.
F2 Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock.
F3 Includes 2 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
F4 Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025.